Penumbra Inc logo

Penumbra Inc

NEW
NYSE:PEN (USA)  
$ 317.75 +0.15 (+0.05%) 10:34 AM EST
78.03
P/B:
8.18
Market Cap:
$ 12.52B
Enterprise V:
$ 12.07B
Volume:
23.84K
Avg Vol (2M):
322.35K
Trade In:
Volume:
23.84K
Avg Vol (2M):
322.35K

PEN Number of Guru Trades

To

PEN Volume of Guru Trades

To

PEN Daily Net ETF Flow

Dollars ETFs put into or pulled out of PEN each day, net of sells, against the share price.

PEN Daily Net ETF Share Flow

Shares ETFs added or removed each day, net, as a share of PEN's shares outstanding, against the share price.

Gurus Latest Trades with NYSE:PEN

No Available Data

NYSE:PEN is held by these investors

Guru
Portfolio Date
Current Shares
% of Shares outstanding
% of Total Assets Managed
Comment
Joel Greenblatt
2026-06-30
32,111
0.080
0.02%
Add 261.81%
Total 1

Top ETF Buyers

What each ETF bought and sold in this stock over the period, from the same daily data as the charts above. Sorted by net amount, so sorting ascending brings the heaviest sellers to the top.

ETF
ETF Name
Net Amount $Mil
Buy Amount $Mil
Sell Amount $Mil
Net Share Change
# of Days Traded
Current Shares
20/Page
Total 0

ETF Ownership

Every ETF holding the stock, largest position first. Change covers the gap between each fund's last two reports, so a fund that held still shows none.

ETF
ETF Name
Shares
% of Shares Out
Change (Last Report)
Action
Report Date
Price Range
20/Page
Total 0

Guru Commentaries on NYSE:PEN

2026 Q1
What the manager wrote

We ended our investment campaigns in Penumbra... The acquisition validated our investment thesis and provided an attractive opportunity to take profits. We had been building the position throughout 2025 as adoption of Penumbra’s core product portfolio expanded and clinical momentum improved across key indications.

2025 Q1
What the manager wrote

Penumbra was one of our medical technology holdings that made positive contributions to relative performance, particularly following favorable stock reactions to quarterly earnings and calendar 2025 guidance. Despite some shorter-term headwinds in the healthcare sector, we believe that the resulting volatility can yield opportunities for favorable long-term returns when quality science and care meet societal health needs.

2025 Q1
What the manager wrote

The manager added Penumbra, Inc. to the portfolio in Q1 2025, indicating a focus on investing in companies with strong business fundamentals and that can sustain high growth. However, there is no explicit directional argument made about the future performance or valuation of Penumbra, Inc.

News about NYSE:PEN

Total 0
  • 1